CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

®: CRE Regulatory Action of the Week

EPA Proposes to Add Pharmaceuticals to RCRA Universal Waste List
The U.S. Environmental Protection Agency is proposing to add hazardous pharmaceutical wastes to the Universal Waste Rule. The Universal Waste Rule, originally promulgated on May 11, 1995, modified the Resource Conservation and Recovery Actís hazardous waste regulations by establishing a set of streamlined requirements for the collection of certain widely-dispersed hazardous wastes, called "universal wastes." The proposed pharmaceutical wastes rule would facilitate the implementation of pharmaceutical take-back programs by removing RCRA barriers in the collection of pharmaceutical wastes from health care and other such regulated facilities, as well as facilitate the collection of pharmaceutical wastes from households, including nonhazardous pharmaceutical wastes.

The proposed rule has not yet been published in the Federal Register. Public comment on the proposed rule must be received on or before 60 days after publication in the Federal Register. However, EPA explains in the proposed rule that "Under the Paperwork Reduction Act, since the Office of Management and Budget (OMB) is required to make a decision concerning the Information Collection Request (ICR) between 30 and 60 days after [publication in the Federal Register], a comment to OMB is best assured of having its full effect if OMB receives it by [30 days after date of publication in the Federal Register]."

  • Click here to read advance copy of Federal Register notice